<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Artificial-Intelligence on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/artificial-intelligence/</link><description>Recent content in Artificial-Intelligence on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 26 Jul 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/artificial-intelligence/index.xml" rel="self" type="application/rss+xml"/><item><title>Sacroiliac Bone Marrow Oedema in the General Population</title><link>https://rheumatologydigest.org/posts/sij-bone-marrow-oedema-general-population/</link><pubDate>Sun, 26 Jul 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/sij-bone-marrow-oedema-general-population/</guid><description>A population-based MRI study of 11,163 German adults found sacroiliac joint bone marrow oedema in about one in three people — roughly 50 times the prevalence of axial spondyloarthritis. The signal tracked with BMI, occupational loading, age and, in women, pregnancy, while chronic back pain barely moved the rate, providing the missing denominator for interpreting a positive SIJ MRI.</description></item></channel></rss>